CLUSTER filed Feb 24, 2026 at 19:00 ET
Three executive insiders at Q32 Bio Inc. (QTTB) sold shares in a coordinated open-market transaction on February 25, 2026, totaling approximately $75,418 in value. The sellers include the CEO, CFO and President, and Chief Scientific Officer, indicating broad-based insider selling at the C-suite level. Given the small total value relative to the company's $59M market cap, this is consistent with routine portfolio management rather than a material negative signal.